FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366602987> ?p ?o ?g. }

• W4366602987 endingPage "11253" @default.
• W4366602987 startingPage "11248" @default.
• W4366602987 abstract "Abstract Introduction In November 2020, the FDA issued an emergency use authorization (EUA) for monoclonal antibody (mAb) therapy in patients with mild‐to‐moderate COVID‐19 at high risk for disease progression. Methods We retrospectively reviewed 38 adult hematology patients who received mAbs from 11/2020 to 2/2021. Results Thirty (79%) patients received bamlanivimab and 8 (21%) casirivimab‐imdevimab. Four (11%) patients were hospitalized due to COVID‐19, two (5%) progressed to severe disease and one patient (3%) died within 30 days from COVID‐19 disease. Most patients ( n = 34, 89%) ultimately tested negative for SARS‐CoV‐2, with 34% ( n = 13) clearing the virus within 14 days after mAb infusion. The median time to clearance of viral shedding was 25.5 days (range: 7–138). After mAb infusion, most patients with hematological malignancies (HM) ( n = 10/15; 67%) resumed therapy for underlying disease with a median delay of 21.5 days (range: 12–42). We observed a significant difference in hospitalization among patients who received a HCT versus non‐HCT (0% n = 0/26 and 36% n = 4/11, respectively; p < 0.01). Conclusions This study demonstrates that SARS‐CoV‐2 specific mAb was safe and may reduce hospitalization compared to what is reported in malignant hematology patients at high risk for disease progression. Our HCT cohort patients had less hospitalization rate compared with HM cohort patients." @default.
• W4366602987 created "2023-04-23" @default.
• W4366602987 creator A5001438849 @default.
• W4366602987 creator A5013241767 @default.
• W4366602987 creator A5020684790 @default.
• W4366602987 creator A5030685440 @default.
• W4366602987 creator A5038541414 @default.
• W4366602987 creator A5039374832 @default.
• W4366602987 creator A5039725610 @default.
• W4366602987 creator A5051751172 @default.
• W4366602987 creator A5052723726 @default.
• W4366602987 creator A5057523501 @default.
• W4366602987 creator A5060959458 @default.
• W4366602987 creator A5063345064 @default.
• W4366602987 creator A5065052780 @default.
• W4366602987 creator A5066354077 @default.
• W4366602987 creator A5068612081 @default.
• W4366602987 creator A5069049786 @default.
• W4366602987 creator A5069640340 @default.
• W4366602987 creator A5070193149 @default.
• W4366602987 creator A5071940265 @default.
• W4366602987 creator A5072775883 @default.
• W4366602987 creator A5078986373 @default.
• W4366602987 creator A5084027789 @default.
• W4366602987 creator A5086494836 @default.
• W4366602987 creator A5091594184 @default.
• W4366602987 date "2023-04-20" @default.
• W4366602987 modified "2023-09-29" @default.
• W4366602987 title "Use of monoclonal antibody therapy in hematologic patients with <scp>mild‐to‐moderate COVID</scp>‐19: A retrospective single‐center experience" @default.
• W4366602987 cites W139458868 @default.
• W4366602987 cites W3009912996 @default.
• W4366602987 cites W3111140326 @default.
• W4366602987 cites W3121319444 @default.
• W4366602987 cites W3125712166 @default.
• W4366602987 cites W3165294072 @default.
• W4366602987 cites W3205344656 @default.
• W4366602987 cites W3210054105 @default.
• W4366602987 cites W4288758289 @default.
• W4366602987 cites W4366602987 @default.
• W4366602987 doi "https://doi.org/10.1002/cam4.5832" @default.
• W4366602987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37081733" @default.
• W4366602987 hasPublicationYear "2023" @default.
• W4366602987 type Work @default.
• W4366602987 citedByCount "1" @default.
• W4366602987 countsByYear W43666029872023 @default.
• W4366602987 crossrefType "journal-article" @default.
• W4366602987 hasAuthorship W4366602987A5001438849 @default.
• W4366602987 hasAuthorship W4366602987A5013241767 @default.
• W4366602987 hasAuthorship W4366602987A5020684790 @default.
• W4366602987 hasAuthorship W4366602987A5030685440 @default.
• W4366602987 hasAuthorship W4366602987A5038541414 @default.
• W4366602987 hasAuthorship W4366602987A5039374832 @default.
• W4366602987 hasAuthorship W4366602987A5039725610 @default.
• W4366602987 hasAuthorship W4366602987A5051751172 @default.
• W4366602987 hasAuthorship W4366602987A5052723726 @default.
• W4366602987 hasAuthorship W4366602987A5057523501 @default.
• W4366602987 hasAuthorship W4366602987A5060959458 @default.
• W4366602987 hasAuthorship W4366602987A5063345064 @default.
• W4366602987 hasAuthorship W4366602987A5065052780 @default.
• W4366602987 hasAuthorship W4366602987A5066354077 @default.
• W4366602987 hasAuthorship W4366602987A5068612081 @default.
• W4366602987 hasAuthorship W4366602987A5069049786 @default.
• W4366602987 hasAuthorship W4366602987A5069640340 @default.
• W4366602987 hasAuthorship W4366602987A5070193149 @default.
• W4366602987 hasAuthorship W4366602987A5071940265 @default.
• W4366602987 hasAuthorship W4366602987A5072775883 @default.
• W4366602987 hasAuthorship W4366602987A5078986373 @default.
• W4366602987 hasAuthorship W4366602987A5084027789 @default.
• W4366602987 hasAuthorship W4366602987A5086494836 @default.
• W4366602987 hasAuthorship W4366602987A5091594184 @default.
• W4366602987 hasBestOaLocation W43666029871 @default.
• W4366602987 hasConcept C126322002 @default.
• W4366602987 hasConcept C159654299 @default.
• W4366602987 hasConcept C167135981 @default.
• W4366602987 hasConcept C194409129 @default.
• W4366602987 hasConcept C203014093 @default.
• W4366602987 hasConcept C2779134260 @default.
• W4366602987 hasConcept C2780073493 @default.
• W4366602987 hasConcept C3008058167 @default.
• W4366602987 hasConcept C524204448 @default.
• W4366602987 hasConcept C542903549 @default.
• W4366602987 hasConcept C71924100 @default.
• W4366602987 hasConcept C72563966 @default.
• W4366602987 hasConcept C90924648 @default.
• W4366602987 hasConceptScore W4366602987C126322002 @default.
• W4366602987 hasConceptScore W4366602987C159654299 @default.
• W4366602987 hasConceptScore W4366602987C167135981 @default.
• W4366602987 hasConceptScore W4366602987C194409129 @default.
• W4366602987 hasConceptScore W4366602987C203014093 @default.
• W4366602987 hasConceptScore W4366602987C2779134260 @default.
• W4366602987 hasConceptScore W4366602987C2780073493 @default.
• W4366602987 hasConceptScore W4366602987C3008058167 @default.
• W4366602987 hasConceptScore W4366602987C524204448 @default.
• W4366602987 hasConceptScore W4366602987C542903549 @default.
• W4366602987 hasConceptScore W4366602987C71924100 @default.
• W4366602987 hasConceptScore W4366602987C72563966 @default.
• W4366602987 hasConceptScore W4366602987C90924648 @default.
• W4366602987 hasIssue "10" @default.

• next